Last Updated : Friday, July 3, 2020 16:47:30

Tag Archives: Cadila Healthcare Ltd

CADILA HEALTH gets DCGI-CDSCO nod for COVID19 vaccine’s human trials

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Pankaj Patel led healthcare service provider and pharmaceutical & wellness products manufacturing Zydus Group’s flagship company Cadila Healthcare Ltd claimed of having successfully completed preclinical development of the company’s vaccine for COVID19 – ZyCoV-D and having received permission

CADILA HEALTH gets USFDA nod to sell medicine to treat blood disorders

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Ahmedabad headquartered Pankaj Patel led healthcare services and pharma & wellness products manufacturing Zydus Group’s flagship company Cadila Healthcare Ltd said of having got USFDA (US Food & Drugs Administration) nod to sell medicine to treat excess iron

CADILA HEALTH ink pact with GILEAD SCIENCES to mfr & mkt REMDESIVIR

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges from Ahmedabad headquartered Pankaj Patel led Zydus Group’s Healthcare Services providing, Pharmaceutical and Wellness products manufacturing Indian company Cadila Healthcare Ltd it said of having inked non-exclusive licensing agreement with Gilead Sciences Inc., to manufacture and market Remdesivir

CADILA HEALTH got USFDA nod to sell medicine, to treat low blood-pressure

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Ahmedabad headquartered pharmaceutical products, healthcare and wellness products manufacturing Indian Company Dr Pankaj Patel led Zydus Group’s pharma products manufacturing arm Cadila Healthcare Ltd said of having got USFDA (US Food and Drugs Administration) nod to sell medicines

CADILA HEALTH gets USFDA nod to sell blood-sugar control tablets for diabetics

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Ahmedabad headquartered pharmaceutical, wellness and healthcare sector Indian company Dr Pankaj Patel owned Zydus Group’s Cadila Healthcare Ltd said of having got USFDA (US Food and Drugs Administration) nod to sell blood-sugar control tablets as administered to diabetic

CADILA HEALTH gets USFDA nod to market tablets to treat Parkinson’s disease

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Ahmedabad headquartered Cadila Healthcare Ltd (Dr Pankaj Patel led Zydus Cadila Group) got USFDA (US Food and Drugs Administration) nod to market tablet to treat Parkinson’s disease or Parkinson’s like symptoms. In a company press-release titled, “Zydus receives

ZYDUS CADILA gets USFDA nod to market affordable anti-diabetic tablet

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Ahmedabad headquartered Dr Pankaj Patel owned Zydus Group’s pharma arm Cadila Healthcare Ltd said of having got nod from USFDA (US Food and Drugs Administration) to market an affordable anti-diabetic tablet Vinglyn, which is now one of the most

CADILA HEALTH (Zydus) acquires 15% stake in two subsidiaries

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Ahmedabad headquartered Cadila Healthcare Ltd said of having acquired 15% stake in two subsidiary companies Zydus Technologies Ltd and Zydus Noveltech Inc., USA. With the balance 15% stake buying Zydus Technologies Ltd in which the company was already holding

Cadila gets USFDA nod to market blood-pressure, heart disease treatment drug

AHMEDABAD | MUMBAI | RAJKOT – In a press-release submitted to the Indian Stock Exchanges, Ahmedabad headquartered pharma major Cadila Healthcare Ltd (Dr. Pankaj Patel led Zydus Cadila Group) said of having got approval from US FDA (Food & Drugs Administration) to market tablets to treat blood-pressure and heart disease. The press-statement, as addressed by

Zydus announces patient enrollment in clinical trials of Saroglitazar

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory filing submitted to the Indian Stock Exchanges, Ahmedabad headquartered Indian Pharma major Cadila Healthcare Ltd (Dr Pankaj Patel led Zydus Group) said of having enrolled patient(s) in evidences VII phase 2 clinical trial of Saroglitazar Magnesium. The company-statement submitted to the Indian Bourses, titled – “Zydus

USFDA classifies Zydus Cadila’s Moraiya unit vide Official Action Initiated

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory updates submitted to the Indian Stock Exchanges, Ahmedabad headquartered Cadila Healthcare Ltd (Dr Pankaj Patel led Zydus Cadila Group) said of its Moraiya facility categorized vide Official Action Initiated by US FDA (Food & Drugs Administration). The statement submitted by the company to the Indian Bourses

Zydus announces completion of Phase III trial of Saroglitazar Magnesium

AHMEDABAB | MUMBAI | RAJKOT – In a press release submitted to the Indian Stock Exchanges, Ahmedabad headquartered Indian pharma major Cadila Healthcare Ltd (Dr Pankaj Patel led Zydus Cadila Group) said of having completed Phase III trials of Saroglitazar Magnesium in Type 2 Diabetes Mellitus. The press release titled, “Zydus Announces Completion of Phase

Zydus Biologics (of Zydus Cadila Group) inspected successfully by US FDA

AHMEDABAD | MUMBAI | RAJKOT – In a press-release submitted to the Indian Bourses, Cadila Healthcare Ltd (Dr Pankaj Patel led Zydus Cadila Group) said of one of the company’s subsidiary facilities being inspected successfully by US Food & Drug Administration. The Company’s Biologics manufacturing facility (Zydus Biologics) located at the Zydus Biotech Park in

Zydus Cadila gets US FDA nod to market osteoporosis, ortho treatment drug

MUMBAI | AHMEDABAD | RAJKOT – Dr Pankaj Patel led and Ahmedabad headquartered Zydus Cadila Group (Cadila Healthcare Ltd) has received final approval from the US regulators to market ortho treatment medicine, the company said in a press release submitted to the Indian Bourses, today. Zydus Cadila has received the final approval from the USFDA

Zydus Cadila keen to set-up mfg facility at Hyderabad, reports Telangana Today

HYDERABAD | AHMEDABAD | RAJKOT – Ahmedabad headquartered and Dr Pankaj Patel led Zydus Cadila Group (Cadila Healthcare Ltd) is keen to establish setting-up a facility in the upcoming Hyderabad Pharma City, Telengana Today reports Quoting Dr Pankaj Patel as told to Telengana Today, the report said of Cadila Healthcare in future to surely look

Zydus Cadila gets US FDA nod to market tablets for diabetic care

AHMEDABAD | MUMBAI | RAJKOT – In a press release submitted to the Indian Bourses on Tuesday, Dr Pankaj Patel led Zydus Cadila group (Cadila Healthcare Ltd.) said of having got approval from US FDA (Food & Drugs Administration) to market Sitagliptin Tablets in dosage value of 25 mg (milligram), 50 mg and 100 mg.

Do NOT follow this link or you will be banned from the site!